-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A Different Option in the Treatment of Transfusion-Dependent Anemia in Lower-Risk MDS

Sponsor: Geron
Program: Product Theaters
Hematology Disease Topics & Pathways:
Bone Marrow Failure Syndromes, Diseases, Myeloid Malignancies
Monday, December 9, 2024: 12:15 PM-1:15 PM
Room 2 (San Diego Convention Center)
Speaker:
Shyamala Navada, MD, Geron
Disclosures:
No relevant conflicts of interest to declare.

This presentation is intended for U.S. based registered meeting attendees

For more information about Geron's products or clinical trials, please contact the Medical Information department at 1-855-GERON-MI (855-437-6664).


For healthcare providers wishing to speak to a Geron Medical Science Liaison, visit https://medinquiry.geron.com/.

See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>